Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joon Ho Moon

Showing results (141-150 of 280) with videos related to

Pageof 28
Sort By:
Annals of Hematology|January 13, 2012
Cyclophosphamide-containing regimen (TCD) is superior to melphalan-containing regimen (MPT) in elderly multiple myeloma patients with renal impairmentMoo-Kon Song, Joo-Seop Chung, Ho-Jin Shin, et al.
Medical Oncology (Northwood, London, England)|May 27, 2010
VARS2 V552V variant as prognostic marker in patients with early breast cancerYee Soo Chae, Soo Jung Lee, Joon Ho Moon, et al.
Journal of Cancer Research and Clinical Oncology|June 23, 2010
RIPK1 and CASP7 polymorphism as prognostic markers for survival in patients with colorectal cancer after complete resectionYee Soo Chae, Jong Gwang Kim, Sang Kyun Sohn, et al.
International Journal of Hematology|July 24, 2012
Polymorphisms of ERCC1 genotype associated with response to imatinib therapy in chronic phase chronic myeloid leukemiaJee Hyun Kong, Yeung-Chul Mun, Seonwoo Kim, et al.
Journal of Clinical Apheresis|September 16, 2009
Mobilization effects of G-CSF, GM-CSF, and darbepoetin-alpha for allogeneic peripheral blood stem cell transplantationShi Nae Kim, Joon Ho Moon, Jong Gwang Kim, et al.
Journal of Korean Medical Science|June 28, 2008
Association of vascular endothelial growth factor gene polymorphisms with susceptibility and clinicopathologic characteristics of colorectal cancerYee Soo Chae, Jong Gwang Kim, Sang Kyun Sohn, et al.
Cancer Research and Treatment|April 14, 2012
Prognostic Impact of Polymorphisms in the CASPASE Genes on Survival of Patients with Colorectal CancerJun Young Choi, Jong Gwang Kim, You Jin Lee, et al.
Annals of Hematology|July 31, 2013
Predictive factors for rapid neutrophil and platelet engraftment after allogenic peripheral blood stem cell transplantation in patients with acute leukemiaHo Sup Lee, Lee Chun Park, Eun Mi Lee, et al.
The Korean Journal of Internal Medicine|January 8, 2025
Reduced-intensity chemotherapy with tyrosine kinase inhibitor followed by allogeneic transplantation is effective in patients with Philadelphia chromosome-positive acute lymphoblastic leukemiaJung Min Lee, Do Young Kim, Hee Jeong Cho, et al.
Yeungnam University Journal of Medicine|October 18, 2019
Chemotherapy adherence is a favorable prognostic factor for elderly patients with multiple myeloma who are treated with a frontline bortezomib-containing regimenHee-Jeong Cho, Sang-Kyung Seo, Dong Won Baek, et al.
Pageof 28

Showing results (141-150 of 280) with videos related to

Sort By:
Pageof 28
Annals of Hematology|January 13, 2012
Cyclophosphamide-containing regimen (TCD) is superior to melphalan-containing regimen (MPT) in elderly multiple myeloma patients with renal impairmentMoo-Kon Song, Joo-Seop Chung, Ho-Jin Shin, et al.
Medical Oncology (Northwood, London, England)|May 27, 2010
VARS2 V552V variant as prognostic marker in patients with early breast cancerYee Soo Chae, Soo Jung Lee, Joon Ho Moon, et al.
Journal of Cancer Research and Clinical Oncology|June 23, 2010
RIPK1 and CASP7 polymorphism as prognostic markers for survival in patients with colorectal cancer after complete resectionYee Soo Chae, Jong Gwang Kim, Sang Kyun Sohn, et al.
International Journal of Hematology|July 24, 2012
Polymorphisms of ERCC1 genotype associated with response to imatinib therapy in chronic phase chronic myeloid leukemiaJee Hyun Kong, Yeung-Chul Mun, Seonwoo Kim, et al.
Journal of Clinical Apheresis|September 16, 2009
Mobilization effects of G-CSF, GM-CSF, and darbepoetin-alpha for allogeneic peripheral blood stem cell transplantationShi Nae Kim, Joon Ho Moon, Jong Gwang Kim, et al.
Journal of Korean Medical Science|June 28, 2008
Association of vascular endothelial growth factor gene polymorphisms with susceptibility and clinicopathologic characteristics of colorectal cancerYee Soo Chae, Jong Gwang Kim, Sang Kyun Sohn, et al.
Cancer Research and Treatment|April 14, 2012
Prognostic Impact of Polymorphisms in the CASPASE Genes on Survival of Patients with Colorectal CancerJun Young Choi, Jong Gwang Kim, You Jin Lee, et al.
Annals of Hematology|July 31, 2013
Predictive factors for rapid neutrophil and platelet engraftment after allogenic peripheral blood stem cell transplantation in patients with acute leukemiaHo Sup Lee, Lee Chun Park, Eun Mi Lee, et al.
The Korean Journal of Internal Medicine|January 8, 2025
Reduced-intensity chemotherapy with tyrosine kinase inhibitor followed by allogeneic transplantation is effective in patients with Philadelphia chromosome-positive acute lymphoblastic leukemiaJung Min Lee, Do Young Kim, Hee Jeong Cho, et al.
Yeungnam University Journal of Medicine|October 18, 2019
Chemotherapy adherence is a favorable prognostic factor for elderly patients with multiple myeloma who are treated with a frontline bortezomib-containing regimenHee-Jeong Cho, Sang-Kyung Seo, Dong Won Baek, et al.
Pageof 28